A DIAGNOSTIC AID in congenital errors of sex development has been established recently in the form of cytological tests of chromosomal sex. These tests do not necessarily indicate the more appropriate clinical and social sex for the patient. In fact, the more suitable sex from the practical point of view is often contrary to the chromosomal sex. Nonetheless, cytological tests of sex have a useful role in indicating the presence of a congenital error in sex development and in clarifying the nature of the abnormality in doubtful cases. In addition, certain important theoretical inferences are being derived from the use of tests of chromosomal sex in developmental abnormalities in man.
study and a more detailed analysis will be presented later. This report is restricted to a general account of the observations with brief reference to their practical and theoretical significance. The majority of the patients are subjects with gonadal dysgenesis ("ovarian" agenesis) or some form of hermaphroditism. For this reason, and because the more significant developments are related to such patients, the observations on these develop. mental errors will be described.
TESTS OF CHROMOSOMAL SEX
The essentials of the cytological tests of sex are as follows. In females, but not in males, the resting nuclei of most tissues contain a special mass of chromatin, the sex chromatin, which is usually located against the inner surface of the nuclear membrane. On the basis of indirect evidence, the female sex chromatin is thought to represent special portions of the two X-chromosomes that adhere to each other. Any chromatin particle that may be formed by the XY-sex chromosome complex of male nuclei is seldom more conspicuous than the other chromatin particles throughout the nucleus. The sex chromatin is not affected by sex hormones.1 Our current knowledge of the structural distinction between male and female cells originated in an observation by the author and E. G. Bertram;2 the subsequent development of the cytological studies and their early application to practical problems have been recorded elsewhere.3
The choice of cells on which to base the cytological test of sex has become partly a matter of personal preference depending on the experience and major interests of the microscopist who assists the clinician. Cells of the Malpighian layer of the epidermis were suggested first4 and their suitability was soon confirmed.5 Our experience has been mainly with skin biopsies. However, epithelial cells in a smear from the oral mucosaC 7 or the mucosa of the reproductive tract8 are satisfactory. These methods are simpler than the study of a skin biopsy and will probably acquire popularity on this account. Whatever method is used, the preparations must be of the highest technical quality since the female sex chromatin is only about one micron in diameter. An interesting and useful variant is the study of blood films.9 In females only, there is an appendage with special characteristics and probably containing the sex chromatin, attached to a lobe of the nucleus in a small proportion of neutrophilic leukocytes.
CLINICAL APPLICATION OF CYTOLOGICAL TESTS OF SEX
Recent observations on gonadal dysgenesis and the main types of hermaphroditism (male pseudohermaphrodite, female pseudohermaphrodite and the true hermaphrodite) will be summarized in this section.
1. Gonadal dysgenesis. -This condition was known as "ovarian" agenesis until recently; its main features are as follows. Clinically, the patients are females who lack properly developed gonads. The external genitalia are female, and a uterus and tubes are present. The gonads take the form of a strand of connective tissue in each broad ligament, containing mesonephric elements but no germ cells or germinal epithelium. The expected signs of cestrogen deprivation become apparent at the age of puberty. These patients are short for their chronological age. Other congenital defects may be present, such as webbing of the neck, cubitus valgus, coarctation of the aorta and defective development of the mandible. Various names have become attached to "ovarian" agenesis combined with other congenital defects; Turner's syndrome is perhaps the best known. The diagnosis can be established by laparotomy or, after the age of 10 to 12 years, by finding an abnormally high level of follicle-stimulating hormone (FSH) in the urine. The cytological tests of sex are useful aids in diagnosis, especially in childhood, as will be noted further on.
The study of patients with "ovarian" agenesis has an interesting history that illustrates how the results of apparently isolated research projects may be related. Several workers, particularly Alfred Jost of Paris, found that early destruction of the fetal gonads in experimental animals was followed consistently by development of the reproductive tract along female lines, even though some of the fetuses were in reality Canad. M. A. J.
Mar. 15, 1956, vol. 74 males. 10 This and other evidence leads to the view that an androgenic hormone elaborated by the fetal testis is required for maturation of the male reproductive system. Jost" and Wilkins'2 suggested, therefore, that a proportion of patients with "ovarian" agenesis may be derived from male embryos that suffered an early failure of development of the embryonal gonads.
When the skin biopsy method of detecting the sex of a patient at the cellular level began to find acceptance, the procedure was applied to subjects with "ovarian" agenesis independently by three groups.'3-'5 The reports were based on a study of 15 patients; the nuclei had a male morphology in 11 cases and a female morphology in 4 cases. Several similar reports have appeared more recently, the most comprehensive being that of Grumbach, Van Wyk and Wilkins,'6 who found that 20 of 22 patients with gonadal dysgenesis, as the condition is now called, had male nuclei and were presumably chromosomal males. Carpentier, Stolte and Visschers reported male nuclei in vaginal smears from 10 of 12 patients with Turner's syndrome. 8 The tests performed in our laboratory also indicate that about 90%o of gonadal dysgenesis subjects have nuclei of the male type. There is presumptive evidence, therefore, in support of the view that in man, as in experimental animals, the fetal testis and its androgenic hormones are necessary to counteract the inherent tendency of the fetus toward feminization. The cause of the failure of gonadal development and the reason for the greater susceptibility of male embryos remain to be explained.
While the cytological tests of sex are useful aids in the diagnosis of gonadal dysgenesis, especially in children, no emphasis in excess of this should be placed on these laboratory procedures. The patients must be regarded as females, clinically and socially, and feminization should be assisted during the appropriate agespan by cestrogens or by cestrogens and progesterone given in a cyclic manner. These patients have feminine psychosexual attitudes since they are regarded as females from birth by parents and associates, and since there is no inconsistency between feminine attitudes and the anatomy of the genitalia.'7 2. Male pseudohermaphroditism. -Patients in this category have testes, but the remainder of the reproductive system is of an intersexual nature and varies from one patient to another.
The external genitalia may be near-male, with such defects as hypospadias and cleft scrotum, while at the other extreme the external genitalia would be considered normal for a female. A uterus and tubes are present in some cases. The testes are usually in the pelvis or inguinal canal and then have the histological structure of undescended testes, with failure of spermatogenesis. The breasts are likely to be undeveloped in adult life, although the secondary sex characteristics are markedly feminine in some instances (testicular feminization).
It has been our experience and the experience of others'8 that male pseudohermaphrodites consistently have male-type nuclei, and presumably XY-sex chromosomes. In view of the experimental studies on gonadectomized embryos and the results of cytological tests of sex in human gonadal dysgenesis, Jost's suggestion'1 that male pseudohermaphroditism is caused by a functional deficiency of the fetal testis with respect to androgen production seems tenable. The variability in feminization from one patient to another may be explained by differences in the degree of hormonal failure and by differences in time relationships. Simple hypospadias may be the result of a mild form of hormonal deficiency of the fetal testis. This hormonal hypothesis for the etiology of male pseudohermaphroditism receives additional support from patients who are intermediate between gonadal dysgenesis and male pseudohermaphroditism, as described by Grumbach, Van Wyk and Wilkins.'6 Patients in the male pseudohermaphrodite group may present a particularly difficult problem in management. The cytological tests of sex are only diagnostic aids, helping to distinguish the male pseudohermaphrodite from the female pseudohermaphrodite when other findings are indefinite. If the patient is seen in infancy, before attitudes in the broad sexual sphere begin to develop, the structure of the external genitalia is the most important single guide to the more appropriate sex from the practical point of view. Later, the sex in which the patient has been raised is a factor of great importance, since a change of status introduces psychological and social difficulties. The timely warning of Wilkins et al. 19 against placing too much emphasis on theoretical considerations in arriving at practical decisions applies to errors of sex development generally, but is especially pertinent to the male pseudohermaphrodite group. The nature of the surgical and hormonal treatment that is so often necessary depends on the decision as to the more appropriate sex, this decision being based on all available findings with emphasis on the anatomy of the external genitalia. Until recent years, the progressive virilization that may occur in patients with the adrenogenital syndrome caused a proportion of them to live as males. Treatment with cortisone, as introduced by Wilkins and collaborators,20 21 was a major therapeutic advance. Small doses reduce the androgenic output of the adrenal cortex, acting apparently through the anterior pituitary, and virilization is brought under control. If these patients are treated sufficiently early in life, reasonably satisfactory orientation in the female direction now seems possible. 4 . True hermaphroditism. -In this comparatively rare condition, the patient has both ovarian and testicular tissue and a variable morphology of the external and internal genitalia. In our experience, the nuclei are female in some patients and male in others, with the former predominating. It follows that the possibility of true hermaphroditism has to be borne in mind when a cytological test of sex is used as a diagnostic aid in hermaphroditism, regard-less of whether the cells have male or female nuclei. The cytological tests are of little help in planning the management of a true hermaphrodite, since a patient with female nuclei may more appropriately live as a male12 and vice versa. As in other errors of sex development, the best guide is external genital anatomy. The cause of true hermaphroditism is unknown although the possibility of there being an unusual sex chromosome complex, such as XXY in some cases, has been suggested.23 SUMMARY Cytological tests of sex, based on the presence of sex chromatin in cells of females, have recently been developed. Cells in sections of epidermis, in smears from oral, cervical or vaginal mucosa, or neutrophils in a blood film may be used. In clinical practice these tests are useful diagnostic aids in gonadal dysgenesis ("ovarian" agenesis) and in some cases of hermaphroditism. The more appropriate sex from clinical and social points of view may be contrary to the type of sex chromosome complex (female XX or male XY), as inferred from the structure of resting nuclei.
In theoretical aspects of sex development, the application of cytological tests to patients with gonadal dysgenesis and male pseudohermaphrodites has yielded results supporting the view that androgenic hormones of the fetal testis are essential for normal maturation of the male reproductive system. RESUME Les epreuves de determination cytologique du sexe basees sur la presence de chromatine du sexe dans les cellules de femelles ont ete recemment mises au point. Les cellules des coupes d'epiderme, de frottis des muqueuses orales, cervicales ou vaginales, ou des neutrophiles du sang peuvent etre employees. En clinique, ces epreuves peuvent aider 'a confirmer le diagnostic de dysgenesie des gonades (agenesie "ovarienne") et de certains cas d'hermaphrodisme. Le sexe le plus convenable du point de vue clinique et social pent etre l'oppose' de celui que revele le complexe des chromosomes (femelles XX-males XY) que presente le noyau a l'etat de repos. D'apres les aspects th6oriques du developpement du sexe, l'application des epreuves cytologiques 'a des patients atteints de dysgenesie des gonades, et 'a des pseudo hermaphrodites males, a donne des resultats appuyant l'opinion voulant que les hormones androgenes des testicules foetales soient essentielles 'a la maturation normale du systeme de reproduction male.
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DE-EPICARDIALIZATION: A SIMPLE, EFFECTIVE SURGICAL TREATMENT
FOR ANGINA PECTORIS Medical or surgical manceuvres designed to increase the blood supply to the human myocardium will require many years for conclusive evaluation. The relief of anginal pain, however, is a more immediately attainable objective. In this paper, there is described a safe procedure that is likely to increase the myocardial blood supply and which on conservative clinical trial relieves pain. The authors consider that it is worthy of further application to patiepts with coronary insufficiency in whom anginal pain is a dominant factor.
The surgical procedure is divided into three parts: (a) exposure of the epicardium and swabbing of the epicardial surface of the heart with 95% phenol; (b) pericardial poudrage with powdered talc; and (e) suture of the pulmonary lingula beneath the pericardium as a source of new blood supply. The writers feel that this operation is much simpler and less dangerous than some of the more complicated procedures for the same purpose, and equally effective.
To date, this operation has been carried out on 18 patients. All but four have had complete relief of pain; two had a recurrence of some angina about two months after operation, but the pain is subsiding in one. Two patients in whom the operation has been less than completely successful have psychiatric problems that render difficult the evaluation of the real anginal residuum.
The writers sound a waming of the obvious futility of attempting to improve the clinical condition of patients with very extensive myocardial damage. They stress that it serves no useful purpose to attempt to provide a blood supply to a scar. On the other hand, they indicate that no patients have been rejected from consideration for operation because of previous coronary occlusions, since more than half of these patients had suffered previous myocardial infarctions. The rather dramatic relief of pain and the simplicity of the operation without surgical mortality suggests that this is a method worthy of continued trial.-D. E. Harken et al., Circulation, 12: 955, 1955.
